Hubei DinglongLtd Past Earnings Performance
Past criteria checks 5/6
Hubei DinglongLtd has been growing earnings at an average annual rate of 35.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.5% per year. Hubei DinglongLtd's return on equity is 11.5%, and it has net margins of 13.1%.
Key information
35.6%
Earnings growth rate
35.7%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 17.5% |
| Return on equity | 11.5% |
| Net Margin | 13.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Estimating The Fair Value Of Hubei Dinglong CO.,Ltd. (SZSE:300054)
Dec 09
Does Hubei DinglongLtd (SZSE:300054) Have A Healthy Balance Sheet?
Nov 22Hubei Dinglong CO.,Ltd.'s (SZSE:300054) 46% Jump Shows Its Popularity With Investors
Oct 08Hubei DinglongLtd's (SZSE:300054) Returns On Capital Are Heading Higher
Sep 08These 4 Measures Indicate That Hubei DinglongLtd (SZSE:300054) Is Using Debt Reasonably Well
Aug 17Market Participants Recognise Hubei Dinglong CO.,Ltd.'s (SZSE:300054) Earnings
Jun 21Hubei DinglongLtd (SZSE:300054) Has More To Do To Multiply In Value Going Forward
May 24Hubei DinglongLtd's (SZSE:300054) Anemic Earnings Might Be Worse Than You Think
Apr 16Hubei Dinglong CO.,Ltd. (SZSE:300054) Released Earnings Last Week And Analysts Lifted Their Price Target To CN¥25.50
Apr 14Is Hubei DinglongLtd (SZSE:300054) Using Too Much Debt?
Mar 30With Hubei Dinglong CO.,Ltd. (SZSE:300054) It Looks Like You'll Get What You Pay For
Feb 28Revenue & Expenses Breakdown
How Hubei DinglongLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,220 | 422 | 394 | 435 |
| 30 Jun 24 | 3,027 | 344 | 365 | 423 |
| 31 Mar 24 | 2,828 | 269 | 356 | 394 |
| 31 Dec 23 | 2,667 | 222 | 338 | 377 |
| 30 Sep 23 | 2,639 | 272 | 321 | 372 |
| 30 Jun 23 | 2,568 | 291 | 314 | 346 |
| 31 Mar 23 | 2,698 | 353 | 310 | 336 |
| 31 Dec 22 | 2,721 | 390 | 318 | 313 |
| 30 Sep 22 | 2,660 | 358 | 310 | 299 |
| 30 Jun 22 | 2,572 | 317 | 319 | 276 |
| 31 Mar 22 | 2,406 | 247 | 310 | 265 |
| 31 Dec 21 | 2,356 | 214 | 296 | 252 |
| 30 Sep 21 | 2,214 | -249 | 361 | 238 |
| 30 Jun 21 | 2,102 | -268 | 346 | 215 |
| 31 Mar 21 | 2,054 | -137 | 343 | 186 |
| 31 Dec 20 | 1,817 | -160 | 330 | 162 |
| 30 Sep 20 | 1,606 | 98 | 294 | 130 |
| 30 Jun 20 | 1,401 | 93 | 267 | 121 |
| 31 Mar 20 | 1,161 | -5 | 236 | 115 |
| 31 Dec 19 | 1,149 | 34 | 220 | 114 |
| 30 Sep 19 | 1,146 | 240 | 178 | 111 |
| 30 Jun 19 | 1,224 | 302 | 172 | 110 |
| 31 Mar 19 | 1,292 | 298 | 172 | 112 |
| 31 Dec 18 | 1,338 | 293 | 178 | 103 |
| 30 Sep 18 | 1,443 | 339 | 163 | 97 |
| 30 Jun 18 | 1,528 | 312 | 132 | 131 |
| 31 Mar 18 | 1,626 | 311 | 153 | 104 |
| 31 Dec 17 | 1,700 | 336 | 167 | 84 |
| 30 Sep 17 | 1,632 | 294 | 193 | 58 |
| 30 Jun 17 | 1,624 | 296 | 250 | 0 |
| 31 Mar 17 | 1,457 | 272 | 226 | 0 |
| 31 Dec 16 | 1,306 | 240 | 207 | 0 |
| 30 Sep 16 | 1,215 | 218 | 174 | 0 |
| 30 Jun 16 | 1,083 | 186 | 152 | 0 |
| 31 Mar 16 | 1,051 | 163 | 143 | 0 |
| 31 Dec 15 | 1,050 | 159 | 143 | 0 |
| 30 Sep 15 | 1,007 | 155 | 143 | 0 |
| 30 Jun 15 | 980 | 145 | 137 | 0 |
| 31 Mar 15 | 986 | 145 | 134 | 0 |
| 31 Dec 14 | 919 | 134 | 122 | 0 |
| 30 Sep 14 | 848 | 122 | 103 | 0 |
| 30 Jun 14 | 710 | 104 | 83 | 0 |
| 31 Mar 14 | 563 | 87 | 69 | 0 |
| 31 Dec 13 | 491 | 75 | 61 | 0 |
Quality Earnings: 300054 has high quality earnings.
Growing Profit Margin: 300054's current net profit margins (13.1%) are higher than last year (10.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300054's earnings have grown significantly by 35.6% per year over the past 5 years.
Accelerating Growth: 300054's earnings growth over the past year (55.4%) exceeds its 5-year average (35.6% per year).
Earnings vs Industry: 300054 earnings growth over the past year (55.4%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 300054's Return on Equity (11.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 22:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hubei Dinglong CO.,Ltd. is covered by 22 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Linlin Li | Central China Securities Co., Ltd. |
| Xiang Zhang | Changjiang Securities Co. LTD. |
| Tai Ma | Changjiang Securities Co. LTD. |